These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3433718)

  • 1. [Can formaldehyde, merthiolate and other vaccine components enhance the anaphylactogenicity of ovalbumin present in inactivated influenza vaccines?].
    Reĭzin FN; Matrosovich MN; Chumakov MP; Mart'ianova LI
    Vopr Virusol; 1987; 32(5):615-6. PubMed ID: 3433718
    [No Abstract]   [Full Text] [Related]  

  • 2. The sensitizing capacity of merthiolate and its methyl analogue.
    Möller H; Trofast J
    J Biol Stand; 1979 Jul; 7(3):153-55. PubMed ID: 500735
    [No Abstract]   [Full Text] [Related]  

  • 3. The adjuvant effect of tuberculin in experimental sensitization to merthiolate.
    Magnusson B; Möller H
    Arch Dermatol Res (1975); 1977 May; 258(3):235-9. PubMed ID: 583641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sensitizing action of nonvirion admixtures in inactivated influenza vaccines in an experiment].
    Bichurina MA; Rozaeva NR; Polianskaia NIu; Zhebrun AB; Barashkova LN
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Dec; (12):36-9. PubMed ID: 6528779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental study of the side effects of the nonvirion admixtures in inactivated influenza vaccines].
    Rozaeva NR; Polianskaia NIu; Bichurina MA; Barashkova LN
    Tr Inst Im Pastera; 1982; 59():121-5. PubMed ID: 7187563
    [No Abstract]   [Full Text] [Related]  

  • 6. [Improved methods of controlling the purity and activity of inactivated influenza vaccines].
    Noskov FS; Bichurina MA; Zhebrun AB; Polianskaia NIu; Kaplun IIa
    Vopr Virusol; 1985; 30(4):409-13. PubMed ID: 3933181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunobiological characteristics of impurities in corpuscular influenza vaccines].
    Zhebrun AB; Bichurina MA; Polianskaia NIu; Rozaeva NR; Fridman EA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Dec; (12):52-5. PubMed ID: 3825357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Laboratory control of the purity of chromatographic influenza vaccine].
    Bichurina MA; Goriunova VV; Zhebrun AB; Chubarova NI
    Tr Inst Im Pastera; 1979; 52():121-8. PubMed ID: 121646
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mercury-induced hypersensitivity rare after subcutaneous injection of vaccines].
    Taranger J
    Lakartidningen; 1990 Apr; 87(16):1345. PubMed ID: 2329881
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunogenic and reactogenic properties of commercial series of inactivated chromatographic influenza vaccine].
    Peĭsel' SG; Nifontova AI; Zhebrun AB; Karpovich NM; Slatin EA
    Tr Inst Im Pastera; 1979; 52():38-42. PubMed ID: 550545
    [No Abstract]   [Full Text] [Related]  

  • 11. Thimerosal-dependent antibody enhanced in the presence of LISS.
    Spencer GT; McDowell MA
    Vox Sang; 1985; 49(6):422-3. PubMed ID: 4090413
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of different methods of determining ovalbumin in preparations of purified influenza virus].
    Bichurina MA; Goriunova VV; Chubarova NI; Zhebruk AB; Noskov FS
    Vopr Virusol; 1981; (2):228-30. PubMed ID: 6791386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed hypersensitivity to thimerosal in contact lens solutions.
    Zeigen SR; Jacobs IH; Weinberger GI
    J Med Soc N J; 1981 May; 78(5):362-4. PubMed ID: 6945439
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-ovalbumin sensitizing ability of influenza vaccines in guinea pigs.
    Weeke-Lüttmann M; Schramm-Thiel N
    Dev Biol Stand; 1977 Jun 1-3; 39():219-222. PubMed ID: 604100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An evaluation of the allergizing properties of merthiolate as a component of adsorbed DTP vaccine].
    Fradkin VA; Lodinova LM; Lavrenchik EI
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (4):38-42. PubMed ID: 7992533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prophylactic effectiveness of an inactivated formol influenza vaccine].
    Agafonov VI; Perepelkin VS; Chemeris EA; Novikov NL
    Voen Med Zh; 1981 Feb; (2):36-8. PubMed ID: 7233843
    [No Abstract]   [Full Text] [Related]  

  • 17. Ovalbumin content in the yellow fever vaccine.
    Smith D; Wong P; Gomez R; White K
    J Allergy Clin Immunol Pract; 2015; 3(5):794-5. PubMed ID: 25912657
    [No Abstract]   [Full Text] [Related]  

  • 18. Two further examples of IgG thimerosal-dependent antibodies and their serological characteristics.
    Valbonesi M; Vassallo F; Lercari G; Frisoni R; Carubia F; Russo E
    Ric Clin Lab; 1987; 17(1):47-51. PubMed ID: 3589402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal vaccination against influenza: protection of pigs immunized with inactivated virus and ether-split vaccine.
    Lim YK; Takada A; Tanizaki T; Ozaki H; Okazaki K; Kida H
    Jpn J Vet Res; 2001 Feb; 48(4):197-203. PubMed ID: 11276584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of formaldehyde in the severity of food anaphylaxis to food model allergen ovalbumin in guinea pigs].
    Pestova MI; Gmoshinskiĭ IV; Mazo VK
    Vopr Pitan; 1993; (3):55-7. PubMed ID: 7975437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.